Eltanexor is under investigation in clinical trial NCT02649790 (Study of the Safety, Tolerability and Efficacy of KPT-8602 in Patients With Relapsed/refractory Cancer Indications).
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.